Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
242.50    7.50 (3.19%)
Bid:
240.00
Ask:
245.00
Spread: 5.00 (2.083%)
Market Cap: £87.20m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

AGM Trading Update

24 Oct 2024 07:00

RNS Number : 3573J
Alumasc Group PLC (The)
24 October 2024
 

24 October 2024

THE ALUMASC GROUP PLC

('Alumasc' or 'the Group')

AGM Trading Update

Positive trading momentum continues

Alumasc, the premium sustainable building products, systems and solutions group, provides the following trading update ahead of its Annual General Meeting, to be held this morning at 10am:

The Group is pleased to announce that, following its record performance for the year to June 2024, the positive trading momentum has continued into the first quarter of the financial year ending 30 June 2025.

The Group continues to outperform the sector, against a challenging backdrop in commercial construction markets, through its strategic focus on sustainable building products and solutions, growing sales through customer service and innovation, and targeted export opportunities.

Management is continuing to take action to increase operating margins towards the medium term 15-20% target set out at Alumasc's recent Capital Markets Event. The consolidation of the Group's access cover manufacturing operation into Halstead, announced in October 2024, is progressing well and the Group's Dover site will close, as planned, at the end of December 2024 delivering an annualised cost reduction of £0.8m p.a.

ARP, acquired in December 2023, continues to perform strongly and the delivery of the initial synergy targets is well advanced.

The Group's balance sheet and cash generation remains strong, supported by continued disciplined management of working capital in the first three months of the financial year.

While demand headwinds in Alumasc's key markets are expected to persist for the rest of 2024, the quality of the Group's businesses and the execution of its well identified strategic priorities means the Board remains confident of delivering another year of growth, in line with its expectations.

Paul Hooper, Chief Executive, commented:

"I am pleased that our strong trading momentum has continued into the new financial year. We continue to demonstrate our ability to outperform our commercial markets, through execution of our proven strategy as outlined at our recent Capital Markets Event. With strong foundations and a clear line of sight to deliver our medium term ambitions, we remain well positioned to deliver significant shareholder value."

Enquiries:

 

The Alumasc Group plc +44 (0)1536 383844

Paul Hooper (Chief Executive)

Simon Dray (Group Finance Director)

Peel Hunt (Broker) +44 (0)207 418 8831

Mike Bell

Ed Allsopp

Cavendish Capital Markets Ltd (Nominated Adviser) +44 (0)207 220 0561

Julian Blunt

Edward Whiley

Camarco (Financial PR) alumasc@camarco.co.uk

Ginny Pulbrook +44 (0)203 757 4992

Rosie Driscoll

Tilly Butcher

 

Notes to Editors:

Alumasc is a UK-based supplier of premium sustainable building products, systems and solutions. Almost 80% of Group sales are driven by building regulations and specifications (architects and structural engineers) because of the performance characteristics offered.

The Group has three business segments with strong positions and brands in their individual markets. The three segments are: Water Management; Building Envelope; and Housebuilding Products.

Alumasc held a Capital Markets Event on 10 October 2024, providing an in-depth look at the Group's strategy across its three divisions, and on the solid foundations which underpin the Group's medium term growth ambitions. A copy of the presentation, and a video recording of the event, are available on the Group's website at www.alumasc.co.uk/investors/news/.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUBDGSBDDGSX
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.